Investigating how DNA-protein crosslink repair affects myeloid leukemias
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
This study is looking at how the body repairs certain DNA damage in people with acute myeloid leukemia (AML) and how this might affect the success of cancer treatments, with the goal of finding better ways to help patients with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10880431 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of DNA-protein crosslink (DPC) repair mechanisms in acute myeloid leukemias (AML). The team is exploring how certain cancer treatments, particularly those that increase DPCs, can impact the effectiveness of therapies. By generating specific antibodies to identify these DPCs, the researchers aim to uncover the biological processes involved in their repair. This could lead to improved treatment strategies for patients with AML, especially those with high case fatality rates.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with acute myeloid leukemia or related myeloid disorders.
Not a fit: Patients with non-myeloid leukemias or those who do not have a diagnosis of leukemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective therapies for patients with acute myeloid leukemia, potentially improving survival rates.
How similar studies have performed: Previous research has shown promising results in understanding DNA repair mechanisms in cancer, indicating that this approach may yield valuable insights.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Kaufmann, Scott H — Mayo Clinic Rochester
- Study coordinator: Kaufmann, Scott H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.